EXOZ
eXoZymes, Inc.
NASDAQ: EXOZ · HEALTHCARE · BIOTECHNOLOGY
$9.98
-3.57% today
Updated 2026-04-30
Market cap
$87.31M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$7 – $18
Volume
0.0M
eXoZymes, Inc. (EXOZ) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — |
| Cost of revenue | $59405.00 | $147751.00 | — | $267382.00 | — |
| Gross profit | $-59405.00 | $-147751.00 | — | $-267382.00 | — |
| Gross margin | — | — | — | — | — |
| R&D | $454454.00 | $348084.00 | $527480.00 | $1.87M | $3.71M |
| SG&A | $838391.00 | $984583.00 | $1.34M | $4.06M | $5.91M |
| Operating income | $-1.29M | $-1.33M | $-1.80M | $-5.93M | $-9.72M |
| Operating margin | — | — | — | — | — |
| EBITDA | $-1.15M | $-1.18M | $-1.60M | $-5.59M | $-9.43M |
| EBITDA margin | — | — | — | — | — |
| EBIT | $-1.21M | $-1.33M | $-1.80M | $-5.86M | $-9.72M |
| Interest expense | — | — | — | — | — |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.21M | $-1.40M | $-2.04M | $-5.86M | $-9.16M |
| Net income growth (YoY) | — | -15.5% | -46.0% | -187.5% | -56.3% |
| Profit margin | — | — | — | — | — |